Home Cart Sign in  
Chemical Structure| 1206711-16-1 Chemical Structure| 1206711-16-1

Structure of DMH-1
CAS No.: 1206711-16-1

Chemical Structure| 1206711-16-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/< 5 nM for ALK1/2/3 respectively and inactive on ALK5, BMPR2, AMPK and VEGFR2.

Synonyms: BMP Inhibitor II; VU036482; DorsoMorphin Homolog 1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DMH-1

CAS No. :1206711-16-1
Formula : C24H20N4O
M.W : 380.44
SMILES Code : CC(C)OC1=CC=C(C2=CN3C(N=C2)=C(C4=CC=NC5=CC=CC=C45)C=N3)C=C1
Synonyms :
BMP Inhibitor II; VU036482; DorsoMorphin Homolog 1
MDL No. :MFCD18384963
InChI Key :JMIFGARJSWXZSH-UHFFFAOYSA-N
Pubchem ID :50997747

Safety of DMH-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • ALK2

    ALK2, IC50:107.9 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
human endometrial stromal cells (HESCs) 0.25 µM 24 hours To investigate the effect of DMH-1 on BMP2-induced ID3 and ICAM1 expression, the results showed that DMH-1 significantly inhibited BMP2-induced upregulation of ID3 and downregulation of ICAM1. PMC9998904
human decidual stromal cells (HDSCs) 0.25 µM 24 hours To investigate the effect of DMH-1 on BMP2-induced ID3 and ICAM1 expression, the results showed that DMH-1 significantly inhibited BMP2-induced upregulation of ID3 and downregulation of ICAM1. PMC9998904
SVOG cells 10 μM 1 hour To investigate the effect of DMH-1 on BMP2-induced GREM2 expression, results showed that DMH-1 completely abolished the BMP2-induced upregulation of GREM2. PMC8626944
SVOG cells 0.25 μM 1 hour DMH-1 completely abolished the BMP2-induced upregulation of CTGF expression PMC8991488

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
rats intraperitoneal injection 1 mg/kg Every 4 days, 3 times induce colorectal cancer PMC9316185

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.63mL

0.53mL

0.26mL

13.14mL

2.63mL

1.31mL

26.29mL

5.26mL

2.63mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories